Skip to main content
Unknown status

Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma

By April 24, 2017No Comments

Condition

Mesothelioma

Estimated Enrollment: 29

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: AAAD4868

Study First Received: October 14, 2009

Last Updated: October 28, 2011

Estimated Primary Completion Date: September 2013

 

Primary Outcome Measures:

Objective tumor response rate

Sponsors and Collaborators:

Columbia University

Website Link: https://ClinicalTrials.gov/show/NCT00996385

Leave a Reply